Global National
September 23 2021 7:53pm

U.S. FDA, CDC support Pfizer-BioNTech boosters for people high-risk or aged 65+

The U.S. Food and Drug Administration (FDA) and an advisory panel for the Centers for Disease Control and Prevention say Americans aged 65 years and older, and those who have a high risk for severe disease should receive a third dose of the Pfizer-BioNTech COVID-19 vaccine. Jackson Proskow reports on if Canada is looking to follow suit, and how scientists feel about the general public getting a third dose.

Video Home